Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients

NCT05870592 is registered in ClinicalTrials.gov with bioAffinity Technologies Inc. as lead sponsor.

NCT NCT05870592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients
Lead sponsor
bioAffinity Technologies Inc.
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2023
Completion date
June 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer